Bulgaria
· Delayed Price · Currency is BGN Biodit AD Statistics
Total Valuation
Biodit AD has a market cap or net worth of BGN 5.19 million. The enterprise value is 5.65 million.
| Market Cap | 5.19M |
| Enterprise Value | 5.65M |
Important Dates
The last earnings date was Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Biodit AD has 14.82 million shares outstanding.
| Current Share Class | 14.82M |
| Shares Outstanding | 14.82M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.14% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.48 |
| PB Ratio | 0.45 |
| P/TBV Ratio | 0.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.40 |
| EV / Sales | 9.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -22.79 |
Financial Position
The company has a current ratio of 4.59, with a Debt / Equity ratio of 0.07.
| Current Ratio | 4.59 |
| Quick Ratio | 1.26 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.44 |
| Interest Coverage | -9.04 |
Financial Efficiency
Return on equity (ROE) is -3.86% and return on invested capital (ROIC) is -2.18%.
| Return on Equity (ROE) | -3.86% |
| Return on Assets (ROA) | -2.15% |
| Return on Invested Capital (ROIC) | -2.18% |
| Return on Capital Employed (ROCE) | -3.68% |
| Revenue Per Employee | 87,429 |
| Profits Per Employee | -65,143 |
| Employee Count | 10 |
| Asset Turnover | 0.05 |
| Inventory Turnover | 0.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.33% in the last 52 weeks. The beta is 0.09, so Biodit AD's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -68.33% |
| 50-Day Moving Average | 0.59 |
| 200-Day Moving Average | 0.99 |
| Relative Strength Index (RSI) | 27.43 |
| Average Volume (20 Days) | 2,069 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biodit AD had revenue of BGN 612,000 and -456,000 in losses.
| Revenue | 612,000 |
| Gross Profit | 502,000 |
| Operating Income | -443,000 |
| Pretax Income | -492,000 |
| Net Income | -456,000 |
| EBITDA | -346,000 |
| EBIT | -443,000 |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 387,000 in cash and 853,000 in debt, giving a net cash position of -466,000 or -0.03 per share.
| Cash & Cash Equivalents | 387,000 |
| Total Debt | 853,000 |
| Net Cash | -466,000 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 11.60M |
| Book Value Per Share | n/a |
| Working Capital | 1.75M |
Cash Flow
In the last 12 months, operating cash flow was -237,000 and capital expenditures -11,000, giving a free cash flow of -248,000.
| Operating Cash Flow | -237,000 |
| Capital Expenditures | -11,000 |
| Free Cash Flow | -248,000 |
| FCF Per Share | -0.02 |
Margins
Gross margin is 82.03%, with operating and profit margins of -72.39% and -74.51%.
| Gross Margin | 82.03% |
| Operating Margin | -72.39% |
| Pretax Margin | -80.39% |
| Profit Margin | -74.51% |
| EBITDA Margin | -56.54% |
| EBIT Margin | -72.39% |
| FCF Margin | n/a |
Dividends & Yields
Biodit AD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -8.79% |
| FCF Yield | -4.78% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |